Bicycle Therapeutics (BCYC)
(Delayed Data from NSDQ)
$23.45 USD
-1.04 (-4.25%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $23.41 -0.04 (-0.17%) 7:02 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-1.26 | 0.00% |
Earnings Summary
For their last quarter, Bicycle Therapeutics (BCYC) reported earnings of -$1.16 per share, beating the Zacks Consensus Estimate of $-1.23 per share. This reflects a positive earnings surprise of 5.69%. Look out for BCYC's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$1.26 per share, reflecting a year-over-year increase of 3.08%.
Earnings History
Price & Consensus
Zacks News for BCYC
Bicycle (BCYC) to Begin Pivotal Bladder Cancer Study, Stock Up
BCYC: What are Zacks experts saying now?
Zacks Private Portfolio Services